Company

Founded in Bielefeld in 2000, PlasmidFactory GmbH is a leading contract development and manufacturing organization (CDMO) of plasmid and Minicircle DNA, providing plasmids and related products to many major national and international customers working in the areas of gene and cell therapy, CAR-T cell development, and genetic vaccination.

Our mission is to apply entrepreneurship to the service of science. We accept no compromises in either quality or competency, and our products and processes are continuously optimized and redeveloped as needed. Our ambition is to drive visionary research with new, compelling ideas and extraordinary techniques, and to foster progress in healthcare by providing customers with exceptionally pure plasmids and Minicircle DNA with which to advance their clinical and research programs.

We are PlasmidFactory, a global CDMO (Contract Development and Manufacturing Organization) based in Bielefeld, Germany, and a trusted partner to biotech and pharmaceutical innovators worldwide. Since 2000, we’ve specialised in the development and production of high-purity plasmid and Minicircle DNA, helping advance gene and cell therapies, CAR-T cell development, viral vector manufacturing, vaccines, and other cutting-edge life-science applications.

Driven by scientific curiosity, uncompromising quality and a deep commitment to our customers’ goals, we combine industry-leading expertise, proprietary technologies and flexible solutions to support research, clinical development and commercialisation at every stage.

Explore the areas from who we are and how we innovate, to careers, news, sustainability and more.

ARCHIMED is acting as a key catalyst for rapid and efficient capacity expansion, exemplified by helping the company move into GMP. Further, ARCHIMED continues PlasmidFactory’s decades of investment in the scientific development of plasmid DNA manufacturing and IP such as the Minicircle, while scaling up the team for the next phase of growth.

With €7.5 billion assets under management across its various funds, ARCHIMED is a leading private equity firm dedicated to investing in the healthcare industries with prioritized areas of focus including Biopharma Products, Consumer Health, Healthcare IT, In Vitro Diagnostics, Life Science Tools & Biologic Services, MedTech, and Pharma Services.

ARCHIMED partners with growing companies in the European and North American mid-cap healthcare sectors, buying stakes in companies, in association with existing owners and managers. It brings decades of medical, scientific, operational, and financial experience, and has identified specific value creation levers to help accomplish its goals of accelerating the growth of its companies and ultimately improving patient outcomes.

The PlasmidFactory team is made up of professionals from diverse scientific backgrounds, including biologists, biotechnologists, chemists, and engineers. It is precisely this diversity of expertise that allows us to tackle challenges from multiple angles using distinct approaches and developing innovative, tailored solutions to our customers‘ needs in collaboration with our own R&D department.

Our philosophy is to manufacture final products with defined quality features within a reasonable timeframe. Every production method is described in written instructions and all processes described in the QM manual are monitored and documented. Regulations in the form of binding SOPs are available for all quality-relevant activities and are continuously updated and expanded. Relevant regulations and statutory provisions are incorporated into our internal processes. All work is carried out by an appropriate number of trained and qualified employees, using suitable resources. This ensures the fulfillment of scientific tasks with the greatest possible expertise. Our organizational structure ensures the effective cooperation of all elements, ensuring optimal quality.